Olov Ekwall

This study identifies parthenolide as a potential therapy for Wiskott-Aldrich syndrome by enhancing megakaryocyte maturation and platelet function in both cell and mouse models.

This paper systematically analyzes how patient variants affect WASp activity, identifying gain-of-function and loss-of-function variants through structural and functional assays.